review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S1040-8428(85)80035-4 |
P698 | PubMed publication ID | 3902261 |
P2093 | author name string | Schulof RS | |
P2860 | cites work | Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by Nα-desacetylthymosin αl | Q72935933 |
‘Nude’, a new hairless gene with pleiotropic effects in the mouse | Q72951103 | ||
AN ELECTRON MICROSCOPIC STUDY OF THYMIC CORPUSCLES IN THE GUINEA PIG AND THE MOUSE | Q76708495 | ||
ULTRASTRUCTURE OF THE FETAL THYMUS IN THE GOLDEN HAMSTER | Q77091601 | ||
Evidence for a serum-factor secreted by the human thymus | Q93729839 | ||
Bioassay determinations of thymopoietin and thymic hormone levels in human plasma | Q24564719 | ||
Complete amino acid sequence of bovine thymosin beta 4: a thymic hormone that induces terminal deoxynucleotidyl transferase activity in thymocyte populations | Q24634732 | ||
Prospective evaluation of thymosin fraction V immunotherapy in patients with non-small cell lung cancer receiving vindesine, doxorubicin, and cisplatin (VAP) chemotherapy. | Q33477816 | ||
Thymosin activity in patients with cellular immunodeficiency | Q33899845 | ||
Thymic hormone-like restoration by human prealbumin of azathioprine sensitivity of spleen cells from thymectomized mice | Q33961910 | ||
Thymic activity in severe combined immunodeficiency diseases | Q35013904 | ||
Suppressor cell regulation of immune response to tumors: Abrogation by adult thymectomy | Q35037736 | ||
Differentiation of population of peripheral blood lymphocytes into cells bearing sheep erythrocyte receptors in vitro by human thymic extract | Q35074327 | ||
Identification of human and rodent thymic epithelium using tetanus toxin and monoclonal antibody A2B5 | Q35202102 | ||
Purification of thymus mRNA coding for a 16,000-dalton polypeptide containing the thymosin alpha 1 sequence | Q35302826 | ||
Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes | Q36259822 | ||
The role of the thymus in development of immunologic capacity in rabbits and mice | Q36266088 | ||
The effects of thymus and other lymphoid organs enclosed in millipore diffusion chambers on neonatally thymectomized mice | Q36267769 | ||
Hormone-like activity of a thymus humoral factor on the induction of immune competence in lymphoid cells | Q36272835 | ||
Thymosins beta 8 and beta 9: two new peptides isolated from calf thymus homologous to thymosin beta 4. | Q36286238 | ||
Synthesis of thymosin beta 4 by peritoneal macrophages and adherent spleen cells | Q36301547 | ||
Expression of receptors for tetanus toxin and monoclonal antibody A2B5 by pancreatic islet cells | Q36308727 | ||
Contribution of zinc and other metals to the biological activity of the serum thymic factor | Q36310852 | ||
Monoclonal antibody against human T cell leukemia virus p19 defines a human thymic epithelial antigen acquired during ontogeny | Q36347553 | ||
Regulation of the immune response by subclasses of T lymphocytes. II. The effect of adult thymectomy upon humoral and cellular responses in mice | Q52245843 | ||
Reduced gonadotropins in athymic mice: prevention by thymic transplantation. | Q54163465 | ||
Solid-phase synthesis of thymosin alpha 1 using tert-butyloxycarbonylaminoacyl-4-(oxymethyl)phenylacetamidomethyl-resin. | Q54543459 | ||
Amino-terminal sequence identity of ubiquitin and the nonhistone component of nuclear protein A24 | Q55066171 | ||
Reduction in the Incidence of Wasting Disease in Neonatally Thymectomized CBA/W Mice by the Injection of Thymosin | Q56802907 | ||
Delayed Effect of Thymectomy in Adult Life on Immunological Competence | Q59055475 | ||
Effect of Thymectomy in Adult Mice on Immunological Responsiveness | Q59076997 | ||
Evidence for a Humoral Thymus Factor Responsible for the Maturation of Immunological Faculty | Q59077053 | ||
Thymosin α1Levels and Helper:Suppressor Ratios in Homosexual Men | Q63353160 | ||
Activation of T-cells rosettes in immunodeficient patients by thymosin | Q66876652 | ||
Immunodeficiency in chronic uremia. Preliminary evidence for thymosin deficiency | Q66879049 | ||
Influenza: Response of T-Cell Lymphopenia to Thymosin | Q66883463 | ||
Immunosuppression and reconstitution with thymosin after radiation therapy | Q66973217 | ||
T-cell abnormalities after mediastinal irradiation for lung cancer. The in vitro influence of synthetic thymosin alpha-1 | Q67274802 | ||
Immunokinetics of a single dose of thymopoietin pentapeptide | Q67278991 | ||
The complete amino acid sequence of ubiquitin, an adenylate cyclase stimulating polypeptide probably universal in living cells | Q67296048 | ||
Evidence for the appearance of non-specific suppressor cells in the blood after local radiation therapy | Q67318187 | ||
Thymosin-induced increase in E-rosette-forming capacity of lymphocytes in patients with malignant neoplasms | Q67323098 | ||
Severe combined immunodeficiency with cartilage-hair hypoplasa: in vitro response to thymosin and attempted reconstitution | Q67869749 | ||
Ultrastructure of the chick thymus | Q68655198 | ||
BCG immunotherapy of malignant melanoma: summary of a seven-year experience | Q68788101 | ||
Peptide and amine producing endocrine-like cells in the chicken thymus. A chemical, histochemical and electron microscopic study | Q70019202 | ||
The Thymus-Adrenal Connection: Thymosin Has Corticotropin-Releasing Activity in Primates | Q70182118 | ||
Increased circulation of T lymphocytes bearing surface thymosin 1 in patients with myasthenia gravis: Effect of thymectomy | Q70239556 | ||
The in vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin's disease | Q70245502 | ||
The thymus gland and reproduction: do thymic peptides influence the reproductive lifespan in females? | Q70254898 | ||
The in vitro effect of a calf thymus extract (thymostimulin) on the immunologic parameters of patients with untreated Hodgkin's disease | Q70265227 | ||
The effect of a human plasma thymic factor on human peripheral blood mononuclear cell subpopulations | Q70440757 | ||
Antigen recognition by T lymphocytes. II. Similar effects of azathioprine, antilymphocyte serum, and anti-theta serum on rosette-forming lymphocytes in normal and neonatally thymectomized mice | Q70454315 | ||
The influence of adult thymectomy on immunological competence as measured by the mixed lymphocyte reaction | Q70521894 | ||
Ability of thymosin to decrease in vivo and in vitro suppressor cell activity in tumor bearing mice and cancer patients | Q70546560 | ||
Human post-thymic precursor cells in health and disease. VI. Effect of serum thymic factor on the response of cells from patients with systemic lupus erythematosus or mixed connective tissue disease in autologous mixed lymphocyte reaction | Q70549529 | ||
Multivariate analysis of T-cell functional defects and circulating serum factors in Hodgkin's disease | Q70553828 | ||
Evidence of the presence in normal serum of a carrier of the serum thymic factor (FTS) | Q70647830 | ||
Thymic hormonal effect on human peripheral blood lymphocytes in vitro. III. Conditions for mixed lymphocyte-tumor culture assay | Q70656741 | ||
Structural requirement for the biological activity of serum thymic factor | Q70667378 | ||
Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases | Q70668032 | ||
Effects of the thymus lymphocytopoietic factor | Q70886244 | ||
Thymostimulin therapy in melanoma patients: correlation of immunologic effects with clinical course | Q70991912 | ||
Complete amino acid sequences of bovine thymopoietins I, II, and III: closely homologous polypeptides | Q70997299 | ||
Early affect of adult thymectomy | Q71054145 | ||
Isolation of thymosin alpha 1 from thymosin fraction 5 of different species by high-performance liquid chromatography | Q71071225 | ||
Automated solid phase synthesis of thymosin alpha 1 | Q71142800 | ||
Thymosin alpha 1 in myasthenia gravis | Q71166812 | ||
Reflections on medical oncology: an appeal for better clinical trials and improved reporting of their results | Q71186777 | ||
The in vivo effect of thymic factor (thymostimulin) administration on circulating immune complexes and serum lysozyme levels in untreated Hodgkin's disease patients | Q71186804 | ||
Thymosin therapy in the DiGeorge syndrome | Q71215422 | ||
Low serum thymic hormone levels in patients with acquired immunodeficiency syndrome | Q71231450 | ||
Improved radioimmunoassay technique for measuring serum thymopoietin | Q71357015 | ||
The hormonal basis of reproductive defects in athymic mice: diminished gonadotropin concentrations in prepubertal females | Q71533152 | ||
Epithelial cell components immunoreact with anti-serum thymic factor (FTS) antibodies: possible association with intermediate-sized filaments | Q71557018 | ||
Elevated serum thymosin alpha 1 levels associated with evidence of immune dysregulation in male homosexuals with a history of infectious diseases or Kaposi's sarcoma | Q71726504 | ||
Effect of thymosin on T-lymphocyte rosette formation in children with kwashiorkor | Q72073526 | ||
An inhibitor of thymic hormone activity in serum from patients with lymphoblastic leukemia | Q72074010 | ||
Serum thymic hormone activity with systemic lupus erythematosus | Q72084556 | ||
Hypoparathyroidism with T-cell deficiency and hypoimmunoglobulinemia: response to thymosin therapy | Q72091259 | ||
In vitro differentiation of human marrow T cell precursors by thymic factors in severe combined immunodeficiency | Q72102517 | ||
Treatment of cell-mediated immunodeficiency with calf thymic hormone (T.P.I.). | Q72113065 | ||
Improvement of impaired leukocyte migration inhibition by thymosin in patients with head and neck squamous carcinoma | Q72154996 | ||
Improvement of cellular immunity and IgA production in immunodeficient children after treatment with synthetic serum thymic factor (FTS) | Q72530650 | ||
Selected phenotypic induction of null lymphocytes from mice with thymic and nonthymic agents | Q72541193 | ||
Monoclonal antibodies to thymosin alpha 1 | Q72731041 | ||
The thymosins—preclinical and clinical studies with fraction V and alpha-i | Q72817409 | ||
Immunologic studies of the acquired immune deficiency syndrome: relationship of immunodeficiency to extent of disease | Q72839218 | ||
A thymus-dependent serum factor induces maturation of thymocytes as evaluated by graft-versus-host reaction | Q72842377 | ||
Fine structure of the epithelial reticular cells of the medulla of the thymus in the golden hamster | Q72928609 | ||
Preparation, assay, and partial purification of a thymic lymphocytopoietic factor (thymosin) | Q36381898 | ||
Specific receptors for the serum thymic factor (FTS) in lymphoblastoid cultured cell lines | Q36389885 | ||
ENHANCEMENT OF IN VIVO INCORPORATION OF LABELED PRECURSORS INTO DNA AND TOTAL PROTEIN OF MOUSE LYMPH NODES AFTER ADMINISTRATION OF THYMIC EXTRACTS | Q36397003 | ||
Keratin cytoskeletons in epithelial cells of internal organs | Q37333405 | ||
Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus. | Q37440454 | ||
Thymosin alpha 11: a peptide related to thymosin alpha 1 isolated from calf thymosin fraction 5 | Q37506962 | ||
Biochemical and biological properties of THF in animal and human models | Q39299472 | ||
Circulating thymic-hormone activity in congenital immunodeficiency | Q39450626 | ||
Immunotherapy and immunopathologic studies in a patient with nucleoside phosphorylase deficiency | Q39606250 | ||
Use of Thymosin in the Treatment of Primary Immunodeficiency Diseases and Cancer | Q39769727 | ||
Increased reactivity of responding cells in the mixed lymphocyte reaction by a thymic humoral factor | Q39788601 | ||
Adult thymectomy prevention of the appearance of suppressor T cells which depress contact sensitivity to picryl chloride and reversal of adult thymectomy effect by thymus extract | Q39802098 | ||
The effect of thymosin on patients with disseminated malignancies.A phase I study | Q39820846 | ||
Effect of Thymic Humoral Factor on Cellular Immune Functions of Normal Children and of Pediatric Patients with Ataxia Telangiectasia and Down's Syndrome | Q39894432 | ||
In vitro and in vivo enhancement of mixed lymphocyte culture reactivity by thymosin in patients with primary immunodeficiency disease | Q39908323 | ||
The isolation of thymopoietin (thymin) | Q39931201 | ||
Thymic factor in human sera demonstrable by a cyclic AMP assay | Q39986606 | ||
Severe disseminated adenovirus infection successfully treated with a thymic humoral factor, THF | Q40076546 | ||
The evolutionary origins of hormones, neurotransmitters, and other extracellular chemical messengers: implications for mammalian biology | Q40086299 | ||
The in vitro induction of differentiation of putative human stem cells by thymosin and agents that affect cyclic AMP | Q40145152 | ||
Purification and properties of bovine thymosin | Q40319653 | ||
Isolation and partial chemical characterization of THF, a thymus hormone involved in immune maturation of lymphoid cells | Q40346934 | ||
Age, Thymic Involution, and Circulating Thymic Hormone Activity* | Q40469783 | ||
Thymosin reconstitution of T cell deficits in vitro in cancer patients | Q40641706 | ||
Induction of Suppressor T Cells in Systemic Lupus Erythematosus by Thymosin and Cultured Thymic Epithelium | Q40652709 | ||
The ultrastructure of the normal human thymus: A study of 36 cases | Q40673182 | ||
Detection of human T-lymphocyte antigens (HTLA antigens) on thymosin-inducible T-cell precursors | Q40676360 | ||
Autologous rosette-forming T cells as the responding cells in human autologous mixed-lymphocyte reaction | Q40687179 | ||
Decreased serum thymic factor activity in asthmatic children | Q40693501 | ||
In Vivo and in Vitro Effects of Thymosin and Adenosine Deaminase on Adenosine-Deaminase-Deficient Lymphocytes | Q40699346 | ||
Thymosin-inducible 'null' cells in atopic eczema | Q40711236 | ||
In vitro thymosin effect on T lymphocytes in alcoholic liver disease | Q40714771 | ||
Immunologic and Clinical Investigation on a Bovine Thymic Extract. Therapeutic Applications in Primary Immunodeficiencies | Q40721958 | ||
Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy | Q40734671 | ||
Presence of thymosin-like factors in human thymic epithelium conditioned medium | Q40739023 | ||
Circulating thymic factor, Facteur Thymique Serique (FTS), in mycosis fungoides and Sezary syndrome | Q41105472 | ||
Clinical trials with thymosin | Q41166424 | ||
Fine structural evidence for hormone secretion by the human thymus | Q41260672 | ||
Myasthenia gravis, thymectomy and serum thymic hormone activity | Q41531626 | ||
Thymosin in the early diagnosis and treatment of high risk homosexuals and hemophiliacs with AIDS-like immune dysfunction | Q41569271 | ||
Activity of synthetic thymosin alpha 1 C-terminal peptides in the azathioprine E-rosette inhibition assay | Q41613283 | ||
A Synthetic Pentapeptide with Biological Activity Characteristic of the Thymic Hormone Thymopoietin | Q41652706 | ||
Synthesis of a proposed thymic factor | Q41692138 | ||
Ultrastructural studies on erythropoiesis in the avian thymus. I. Description of cell types | Q41730188 | ||
Thymic hormone-containing cells. Characterization and localization of serum thymic factor in young mouse thymus studied by monoclonal antibodies | Q41964818 | ||
Radioimmunoassays for the thymic hormone serum thymic factor (FTS). | Q42258794 | ||
Thymopoietin-like Substance in Human Skin | Q42454921 | ||
Isolation of bovine thymin: a polypeptide hormone of the thymus | Q43735353 | ||
The effect of thymosin on human T-cells from cancer patients | Q43755223 | ||
Thymin: a thymic polypeptide causing the neuromuscular block of myasthenia gravis | Q43813597 | ||
Synthesis of the nonatetracontapeptide corresponding to the sequence proposed for thymopoietin II | Q44293254 | ||
Influence of Thymosin on Immunological Competence of Lymphoid Cells from Thymectomized Mice | Q44378141 | ||
Inverse correlation between age related abnormalities of T-cell immunity and circulating thymosin α1levels in haemophilia A | Q44658140 | ||
Antibody to Human T-Cell Leukemia Virus Membrane Antigens, Beta_2-Microglobulin Levels, and Thymosin Alpha_1 Levels in Hemophiliacs and Their Spouses | Q45797262 | ||
Sample size nomograms for interpreting negative clinical studies | Q47251269 | ||
Origin of immunoreactive lymphocytes in rats | Q47735301 | ||
Production of biologically active N alpha-desacetylthymosin alpha 1 in Escherichia coli through expression of a chemically synthesized gene | Q48411482 | ||
P433 | issue | 4 | |
P304 | page(s) | 309-376 | |
P577 | publication date | 1985-01-01 | |
P1433 | published in | Critical Reviews in Oncology Hematology | Q15724423 |
P1476 | title | Thymic peptide hormones: basic properties and clinical applications in cancer | |
P478 | volume | 3 |
Q90292811 | A Reappraisal of Thymosin Alpha1 in Cancer Therapy |
Q70378746 | A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission |
Q33517999 | Aqueous extracts from dietary supplements influence the production of inflammatory cytokines in immortalized and primary T lymphocytes |
Q69739688 | Development of thymocytes in organ culture: migrant cells with natural killer cell characteristics |
Q69395979 | Growth hormone treatment stimulates thymulin production in aged dogs |
Q43853516 | Involvement of mitogen-activated protein kinases in the signal transduction pathway of bone marrow-derived macrophage activation in response to in vitro treatment with thymosin alpha 1. |
Q69616835 | Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin |
Q37395527 | Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones |
Q42805123 | Prothymosin alpha promotes cell proliferation in NIH3T3 cells. |
Q37988329 | Prothymosin alpha: a ubiquitous polypeptide with potential use in cancer diagnosis and therapy |
Q24628113 | The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA |
Q34452145 | Thymic hormones in cancer diagnostics and treatment |
Q24236667 | Thymic peptides for treatment of cancer patients |
Q38871798 | Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway |
Q44538537 | Thymostimulin treatment in AIDS-related complex |